What are the most common side effects of SOLIFENACIN SUCCINATE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for SOLIFENACIN SUCCINATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is SOLIFENACIN SUCCINATE the same as solifenacin succinate?

solifenacin succinate is a brand name for SOLIFENACIN SUCCINATE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

SOLIFENACIN SUCCINATE

Q: What is SOLIFENACIN SUCCINATE used for?

SOLIFENACIN SUCCINATE (brand name solifenacin succinate) is a Other indicated for 1 INDICATIONS AND USAGE Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence.

Q: How does SOLIFENACIN SUCCINATE work?

SOLIFENACIN SUCCINATE works through the following mechanism: 12.1 Mechanism of Action Solifenacin is a competitive muscarinic receptor antagonist. Muscarinic receptors play an important role in several major cholinergically mediated functions, including contractions of urinary bladder smooth muscle..

Other

Brand names: solifenacin succinate, Vesicare

Oral

Mechanism of Action

12.1 Mechanism of Action Solifenacin is a competitive muscarinic receptor antagonist. Muscarinic receptors play an important role in several major cholinergically mediated functions, including contractions of urinary bladder smooth muscle.

Indications

1 INDICATIONS AND USAGE Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence

urgency

and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence

urgency

and urinary frequency ( 1 ).

Contraindications

• 4 CONTRAINDICATIONS Solifenacin succinate tablets are contraindicated in patients: • With urinary retention [ see Warnings and Precautions ( 5.2 ) ]
• • With gastric retention [ see Warnings and Precautions ( 5.3 ) ]
• • With uncontrolled narrow-angle glaucoma [ see Warnings and Precautions ( 5.5 ) ]
• 5.2 ). • Gastric retention ( 4
• 5.3 ). • Uncontrolled narrow-angle glaucoma ( 4

FDA Warnings

5 WARNINGS AND PRECAUTIONS • Angioedema and Anaphylactic Reactions : Promptly discontinue solifenacin succinate and provide appropriate therapy ( 5
• QT Prolongation in Patients at High Risk of QT Prolongation : Solifenacin succinate is not recommended for use in patients at high risk of QT prolongation, including patients with a known history of QT prolongation and patients taking medications known to prolong the QT interval ( 5
Solifenacin succinate is contraindicated in patients with a known or suspected hypersensitivity to solifenacin succinate [ see Contraindications ( 4 ) ]
The use of solifenacin succinate is not recommended in patients with clinically significant bladder outlet obstruction and is contraindicated in patients with urinary retention [ see Contraindications ( 4 ) ]

Known Side Effects

13 documented side effects by frequency

Drug Not Working

>10%

Dry Mouth

1-10%

Constipation

1-10%

Fatigue

1-10%

Falls

1-10%

Dizziness

1-10%

Nausea

1-10%

Headache

0.1-1%

Blurred Vision

0.1-1%

UTI

0.1-1%

Diarrhea

0.1-1%

Weakness

0.1-1%

General Unwellness

0.1-1%

Community Discussions

No community discussions found for SOLIFENACIN SUCCINATE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → SOLIFENACIN SUCCINATE openFDA label JSON → SOLIFENACIN SUCCINATE FAERS adverse-event reports → SOLIFENACIN SUCCINATE ClinicalTrials.gov → completed Phase 2+ trials of SOLIFENACIN SUCCINATE

Compare With

0 available comparisons

No comparisons yet.

Formulations

Dosage Forms

Tablet

Route

Oral